Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)

SHA:688062 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15,744	8,072	13,063	5,774	-	-
Market Cap Growth	85.85%	-38.21%	126.23%	-	-	-
Enterprise Value	16,996	8,656	12,397	3,618	-	-
Last Close Price	39.42	20.20	32.69	14.45	-	-
PS Ratio	25.21	40.40	102.19	208.24	-	-
PB Ratio	16.65	5.19	5.08	1.65	-	-
P/TBV Ratio	31.86	6.22	5.62	1.79	-	-
EV/Sales Ratio	27.21	43.33	96.98	130.47	-	-
Debt / Equity Ratio	2.70	1.42	0.50	0.22	0.33	0.03
Asset Turnover	0.14	0.05	0.03	0.01	0.01	0.00
Inventory Turnover	0.31	0.19	0.06	0.03	0.14	0.17
Quick Ratio	0.77	0.89	2.24	5.92	0.48	3.60
Current Ratio	0.90	1.11	2.51	6.24	0.91	4.00
Return on Equity (ROE)	-66.66%	-50.69%	-34.81%	-42.40%	-62.34%	-57.78%
Return on Assets (ROA)	-12.17%	-14.71%	-14.98%	-20.16%	-30.98%	-30.80%
Return on Invested Capital (ROIC)	-14.48%	-16.81%	-16.68%	-22.26%	-34.98%	-36.66%
Return on Capital Employed (ROCE)	-37.10%	-37.60%	-29.90%	-24.00%	-60.50%	-45.40%
Earnings Yield	-6.02%	-12.93%	-8.06%	-16.54%	-	-
FCF Yield	-3.98%	-15.94%	-9.82%	-21.89%	-	-
Buyback Yield / Dilution	-0.50%	-0.24%	-1.93%	-30.74%	-5.32%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.